Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

(TTXVN/Vietnam+) 09:51 23/10/2020

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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